Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

(TTXVN/Vietnam+) 09:51 23/10/2020

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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